Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

(TTXVN/Vietnam+) 09:51 23/10/2020

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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